<html>

<head>
<meta content="text/html; charset=utf-8" />


<title>M2950303.DOC;1</title>



</head>

<body>



<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">UNITED STATES </font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">SECURITIES AND
EXCHANGE COMMISSION</font></p>

<p align=center style="margin:0in;margin-bottom:.25in;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">WASHINGTON,
D.C. 20549</font></p>

<p align=center style="margin:0in;margin-bottom:.25in;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">FORM
8-K</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">CURRENT REPORT
PURSUANT</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">TO SECTION 13 or
15(d) OF THE</font></p>

<p align=center style="margin:0in;margin-bottom:12.0pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">SECURITIES
EXCHANGE ACT OF 1934</font></p>

<p align=center style="margin:0in;margin-bottom:.25in;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Date
of report (Date of earliest event reported): February 16, 2012</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Medytox Solutions, Inc.</font></p>

<p align=center style="margin:0in;margin-bottom:12.0pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">(Exact
Name of Registrant as Specified in Its Charter)</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Nevada</font></p>

<p align=center style="margin:0in;margin-bottom:12.0pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">(State
or Other Jurisdiction of Incorporation)</font></p>

<div align=center>

<table border=0 cellpadding=0 cellspacing=0 style="margin-left:0pt;width:0px;">
 <tr>
  <td valign=top width=48% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">000-54346</font></p>
  </td>
 <td valign=top width=52% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">54-2156042</font></p>
  </td>
 </tr>
<tr>
  <td valign=top width=48% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Commission File
  Number)</font></p>
  </td>
 <td valign=top width=52% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(I.R.S. Employer
  Identification No.)</font></p>
  </td>
 </tr>
</table>

</div>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<div align=center>

<table border=0 cellpadding=0 cellspacing=0 style="width:0px;">
 <tr>
  <td valign=top width=77% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">400 S. Australian
  Avenue, Suite 800, West Palm Beach, Florida</font></p>
  </td>
 <td valign=top width=23% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">33401</font></p>
  </td>
 </tr>
<tr>
  <td valign=top width=77% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Address of
  Principal Executive Offices)</font></p>
  </td>
 <td valign=top width=23% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Zip Code)</font></p>
  </td>
 </tr>
</table>

</div>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<div align=center align=left><table border=0 cellpadding=0 cellspacing=0 style="width:0px;">
 <tr>
  <td align=center valign=top width=100% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(561) 855-1626</font></p>
  </td>
 </tr>
<tr>
  <td align=center valign=top width=100% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Registrant&#8217;s
  Telephone Number, Including Area Code)</font></p>
  </td>
 </tr>
</table></div>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<div align=center =left><table border=0 cellpadding=0 cellspacing=0 style="width:0px;">
 <tr>
  <td valign=top width=100% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">&nbsp;</font></p>
  </td>
 </tr>
<tr>
  <td align=center valign=top width=100% style="padding:0in 0in 0in 0in;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">(Former Name or
  Former Address, if Changed Since Last Report)</font></p>
  </td>
 </tr>
</table></div>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">[ ] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">[ ] &#160;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">[ ] &#160;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))</font></p>

<p align=left style="margin:0in;margin-bottom:12.0pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">[ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))</font></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;page-break-after:avoid;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;font-weight:normal;">1</font></p>

<p align=center style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;text-indent:0in;"><font face="Times New Roman,serif" lang=X-NONE style="font-size:12.0pt;">_____________________________________________</font></p>




<p style="margin:0in;margin-bottom:.0001pt;text-align:justify;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Section 1 &#8211;
Registrant's Business and Operations</font></b></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;text-indent:.5in;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Item
1.01.&#160; Entering into a Material Definitive Agreement </font></b></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">On February
16, 2012, Medytox Diagnostics, Inc. (&quot;Medytox&quot;), a wholly-owned
subsidiary of Medytox Solutions, Inc., entered into a Membership Interest
Purchase Agreement (the &quot;Agreement&quot;) for the purchase of 50.5% of the
outstanding membership interests in Collectaway, LLC (&quot;Collectaway&quot;)
from Marylu Villasenor-Hill, previously the sole member of Collectaway (the
&quot;Seller&quot;).&#160; Collectaway is a licensed clinical laboratory and an
enrolled Medicare provider.&#160; </font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">The total
purchase price for the membership interests was $201,000, consisting of a
payment of $1,000 at closing and the delivery of a $200,000 promissory note by
Medytox.&#160; The transaction was entered into and closed on February 16, 2012.&#160;
The Agreement contains customary representations, warranties and covenants of
the parties.&#160; Each party agreed to indemnify the other in the event of any
breaches of applicable representations and warranties.&#160; The note bears interest
at the rate of 5% and is due on February 15, 2013 (the &quot;Maturity
Date&quot;).&#160; Four principal payments of $50,000 will be made every three months,
with the final payment (and all accrued interest) being due on the Maturity
Date. The note may be prepaid at any time without premium or penalty.&#160; The note
is secured by the membership interests purchased by Medytox.&#160; The note may be
accelerated by the Seller in the event of nonpayment by Medytox after notice or
upon certain bankruptcy events relating to Medytox.&#160; </font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">There are no
material relationships between the Company, Medytox or any of their affiliates
and the Seller, other than with respect to the Agreement.</font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">The foregoing
is qualified in its entirety by reference to the Agreement, a copy of which is
filed herewith as Exhibit 10.1, and the promissory note, a copy of which is
filed herewith as Exhibit 10.2.</font></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:justify;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Section 2 &#8211; Financial Information</font></b></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:justify;text-indent:.5in;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Item 2.03. Creation of a Direct Financial Obligation or
an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</font></b></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">The information set forth above in Item 1.01 is
incorporated by reference.</font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Section 9 &#8211; Financial
Statement and Exhibits</font></b></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Item 9.01.
Financial Statements and Exhibits</font></b></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;page-break-after:avoid;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;font-weight:normal;">2</font></p>

<p align=center style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;text-indent:0in;"><font face="Times New Roman,serif" lang=X-NONE style="font-size:12.0pt;">_____________________________________________</font></p>

<p style="margin:0in;margin-bottom:12.0pt;text-align:justify;text-indent:.5in;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p style="margin:0in;margin-bottom:12.0pt;page-break-after:avoid;text-align:justify;text-indent:.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">(d)&#160; Exhibits</font></p>

<div align=left><table border=0 cellpadding=0 cellspacing=0 style="border-collapse:collapse;width:0px;">
 <tr style="height:22.05pt;page-break-inside:avoid;">
  <td valign=top width=50% style="height:22.05pt;padding:0in 5.4pt 0in 5.4pt;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;page-break-after:avoid;text-align:center;"><u><font face="Times New Roman,serif" style="font-size:12.0pt;">Exhibit Number</font></u></p>
  </td>
 <td valign=top width=50% style="height:22.05pt;padding:0in 5.4pt 0in 5.4pt;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><u><font face="Times New Roman,serif" style="font-size:12.0pt;">Description</font></u></p>
  </td>
 </tr>
<tr style="height:58.5pt;page-break-inside:avoid;">
  <td valign=top width=50% style="height:58.5pt;padding:0in 5.4pt 0in 5.4pt;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">10.1</font></p>
  </td>
 <td valign=top width=50% style="height:58.5pt;padding:0in 5.4pt 0in 5.4pt;">
  <p style="margin:0in;margin-bottom:.0001pt;text-align:justify;"><font face="Times New Roman,serif" style="font-size:12.0pt;">Membership Interest Purchase Agreement, dated as of
  February 16, 2012, between Marylu Villasenor-Hill and Medytox Diagnostics,
  Inc.</font></p>
  </td>
 </tr>
<tr style="height:58.5pt;page-break-inside:avoid;">
  <td valign=top width=50% style="height:58.5pt;padding:0in 5.4pt 0in 5.4pt;">
  <p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" style="font-size:12.0pt;">10.2</font></p>
  </td>
 <td valign=top width=50% style="height:58.5pt;padding:0in 5.4pt 0in 5.4pt;">
  <p style="margin:0in;margin-bottom:.0001pt;text-align:justify;"><font face="Times New Roman,serif" style="font-size:12.0pt;">Secured Promissory Note, dated February 16, 2012, issued
  by Medytox Diagnostics, Inc. to Marylu Villasenor-Hill</font></p>
  </td>
 </tr>
</table></div>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;page-break-after:avoid;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;page-break-after:avoid;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;font-weight:normal;">3</font></p>

<p align=center style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;text-indent:0in;"><font face="Times New Roman,serif" lang=X-NONE style="font-size:12.0pt;">_____________________________________________</font></p>




<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;page-break-after:avoid;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">SIGNATURES</font></b></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:justify;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized. </font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Date: February 17, 2012&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; MEDYTOX
SOLUTIONS, INC.</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">/s/
William G. Forhan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></u></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; William
G. Forhan,</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; CEO,
CFO and Chairman</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (principal
executive officer)</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">4</font></p>

<p align=center style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;text-indent:0in;"><font face="Times New Roman,serif" lang=X-NONE style="font-size:12.0pt;">_____________________________________________</font></p>

<p align=left style="margin:0in;margin-bottom:.0001pt;text-align:left;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>








<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">EXHIBIT INDEX</font></b></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p align=center style="margin:0in;margin-bottom:.0001pt;text-align:center;"><b><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></b></p>

<p style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:justify;"><u><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Exhibit No.</font></u><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">Description&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></u></p>

<p style="margin-bottom:12.0pt;margin-left:1.5in;margin-right:0in;margin-top:0in;text-align:justify;text-indent:-1.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">10.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Membership
Interest Purchase Agreement, dated as of February 16, 2012, between Marylu
Villasenor-Hill and Medytox Diagnostics, Inc.</font></p>

<p style="margin-bottom:12.0pt;margin-left:1.5in;margin-right:0in;margin-top:0in;text-align:justify;text-indent:-1.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">10.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Secured
Promissory Note, dated February 16, 2012, issued by Medytox Diagnostics, Inc.
to Marylu Villasenor-Hill</font></p>

<p align=center style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;text-indent:0in;"><font face="Times New Roman,serif" lang=X-NONE style="font-size:12.0pt;">&nbsp;</font></p>

<p align=center style="margin-bottom:12.0pt;margin-left:0in;margin-right:0in;margin-top:0in;text-align:center;text-indent:0in;"><font face="Times New Roman,serif" lang=X-NONE style="font-size:12.0pt;">_____________________________________________</font></p>

<p style="margin-bottom:12.0pt;margin-left:1.5in;margin-right:0in;margin-top:0in;text-align:justify;text-indent:-1.5in;"><font face="Times New Roman,serif" lang=EN-US style="font-size:12.0pt;">&nbsp;</font></p>






</body>

</html>
[{"type": "8-K", "sequence": "1", "filename": "msi8k021712.htm", "secsgml_size_bytes": 25668}]
{"company-data": {"conformed-name": "Medytox Solutions, Inc.", "cik": "0001374536", "assigned-sic": "8734", "irs-number": "542156042", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54346", "film-number": "12622844"}, "business-address": {"street1": "400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR", "city": "WEST PALM BEACH", "state": "FL", "zip": "33401", "phone": "(561) 855-1626"}, "mail-address": {"street1": "400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR", "city": "WEST PALM BEACH", "state": "FL", "zip": "33401"}, "former-company": {"former-conformed-name": "CASINO PLAYERS, INC.", "date-changed": "20060905"}}
M2950303.DOC;1
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 or
15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): February 16, 2012
Medytox Solutions, Inc.
(Exact
Name of Registrant as Specified in Its Charter)
Nevada
(State
or Other Jurisdiction of Incorporation)
000-54346
54-2156042
(Commission File
  Number)
(I.R.S. Employer
  Identification No.)
400 S. Australian
  Avenue, Suite 800, West Palm Beach, Florida
33401
(Address of
  Principal Executive Offices)
(Zip Code)
(561) 855-1626
(Registrant's
  Telephone Number, Including Area Code)
(Former Name or
  Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[ ] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]  Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]  Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
1
_____________________________________________
Section 1 –
Registrant's Business and Operations
Item
1.01.  Entering into a Material Definitive Agreement
On February
16, 2012, Medytox Diagnostics, Inc. ("Medytox"), a wholly-owned
subsidiary of Medytox Solutions, Inc., entered into a Membership Interest
Purchase Agreement (the "Agreement") for the purchase of 50.5% of the
outstanding membership interests in Collectaway, LLC ("Collectaway")
from Marylu Villasenor-Hill, previously the sole member of Collectaway (the
"Seller").  Collectaway is a licensed clinical laboratory and an
enrolled Medicare provider.
The total
purchase price for the membership interests was $201,000, consisting of a
payment of $1,000 at closing and the delivery of a $200,000 promissory note by
Medytox.  The transaction was entered into and closed on February 16, 2012. 
The Agreement contains customary representations, warranties and covenants of
the parties.  Each party agreed to indemnify the other in the event of any
breaches of applicable representations and warranties.  The note bears interest
at the rate of 5% and is due on February 15, 2013 (the "Maturity
Date").  Four principal payments of $50,000 will be made every three months,
with the final payment (and all accrued interest) being due on the Maturity
Date. The note may be prepaid at any time without premium or penalty.  The note
is secured by the membership interests purchased by Medytox.  The note may be
accelerated by the Seller in the event of nonpayment by Medytox after notice or
upon certain bankruptcy events relating to Medytox.
There are no
material relationships between the Company, Medytox or any of their affiliates
and the Seller, other than with respect to the Agreement.
The foregoing
is qualified in its entirety by reference to the Agreement, a copy of which is
filed herewith as Exhibit 10.1, and the promissory note, a copy of which is
filed herewith as Exhibit 10.2.
Section 2 – Financial Information
Item 2.03. Creation of a Direct Financial Obligation or
an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth above in Item 1.01 is
incorporated by reference.
Section 9 – Financial
Statement and Exhibits
Item 9.01.
Financial Statements and Exhibits
2
_____________________________________________
(d)  Exhibits
Exhibit Number
Description
10.1
Membership Interest Purchase Agreement, dated as of
  February 16, 2012, between Marylu Villasenor-Hill and Medytox Diagnostics,
  Inc.
10.2
Secured Promissory Note, dated February 16, 2012, issued
  by Medytox Diagnostics, Inc. to Marylu Villasenor-Hill
3
_____________________________________________
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: February 17, 2012                                             MEDYTOX
SOLUTIONS, INC.
/s/
William G. Forhan
William
G. Forhan,
CEO,
CFO and Chairman
(principal
executive officer)
4
_____________________________________________
EXHIBIT INDEX
Exhibit No.
Description
10.1                             Membership
Interest Purchase Agreement, dated as of February 16, 2012, between Marylu
Villasenor-Hill and Medytox Diagnostics, Inc.
10.2                             Secured
Promissory Note, dated February 16, 2012, issued by Medytox Diagnostics, Inc.
to Marylu Villasenor-Hill
_____________________________________________